Drug Target Review – Issue 4 2020
Posted: 26 November 2020 | Drug Target Review | No comments yet
In this journal, find articles discussing antimicrobial resistance, exploring why inhibiting the interaction between SARS-CoV-2 and neuropilin-1 could help combat COVID-19, as well as how CRISPR can be used to enhance productivity in cell line development. Also in this issue, features on engineering new biologic drugs and precision medicine.
Included in this issue:
- SCREENING
Genetic screening to predict the risk of future diseases
Pushpanathan Muthuirulan, Harvard University
Antimicrobial resistance – a public health emergency on the horizon
Jack Kay, University of Plymouth and Ingenza Ltd - COVID-19
Development of a physiologically relevant lung model for understanding SARS-CoV-2 infection
Lyle Armstrong, Newcastle University and Newcells Biotech
Investigating cellular pathways driving severe COVID-19 with proteomics
Mike Filbin, Massachusetts General Hospital - LABEL FREE
A label-free imaging technique for drug evaluation at single‑cell level
Arno Germond, RIKEN Center for Biosystems Dynamics Research - UPSTREAM BIOPROCESSING
Biosynthetic polysaccharidebased drugs and nutraceuticals from non-animal sources
Robert J Linhardt and Payel Datta, Rensselaer Polytechnic Institute - NGS
Tracking SARS-CoV- 2 with genome sequencing
Nikki Withers, Drug Target Review - GENOMICS
Predicting COVID-19 susceptibility and severity
Cathy Ball, AncestryDNA
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Antimicrobials, Biologics, Cell culture, Disease research, Drug Development, Genomics, Imaging, Oncology, Therapeutics
Related conditions
Antimicrobial resistance (AMR), Covid-19
